HVD(P)s: steady state = history [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2024-12-04 10:37 (197 d 17:56 ago) – Posting: # 24308
Views: 4,238

Hi Libaiyi,

steady state studies were proposed for Highly Variable Drugs / Drug Products in the 1990s.1–4 Consequently, they were also recommended in a European Note for Guidance.5 However, this recommendation was removed in the final version6 because single dose studies are more sen­sitive in detecting potential differences in formulations (especially of the rate of absorption Cmax / tmax).

It is notable that none of the extant guidelines offer steady state studies as a viable alternative to single dose for HVD(P)s. Consider reference-scaling instead.


  1. Midha KK, Blume HH, editors. Bio-International. Bioavailability, Bio­equi­va­lence and Pharmacokinetics. Stutt­gart: med­pharm; 1993. ISBN 3-88763-019-X.
  2. Blume HH, Midha KK. Bio-International 92, Conference on Bioavailability, Bio­equi­va­lence, and Pharmacokinetic Studies. J Pharm Sci. 1993; 82(11): 1186–9. doi:10.1002/jps.2600821125.
  3. Blume H, Zhong D, Elze M, Wendt G, Schug B, Scheidel B, Hutt HJ, Hagenlocher M. Advantages of a steady-state crossover design in assessment of bioequivalence of highly variable drugs: propafenone. Europ J Pharmaceut Sci. 1994; 385–93. doi:10.1016/0928-0987(94)00068-9.
  4. Blume HH, Midha KK, editors. Bio-International 2. Bioavailability, Bioequivalence and Pharmacokinetic Studies. Stutt­gart: med­pharm; 1995. ISBN 3-88763-040-8.
  5. EMEA Human Medicines Evaluation Unit / CPMP. Note for Guidance on the In­ves­tigation of Bioavailability and Bio­equi­va­lence. Draft. London. 17 December 1998.
  6. EMEA, CPMP. Note for Guidance on the Investigation of Bioavailability and Bio­equi­va­lence. London. 26 July 2001. Online.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,676 registered users;
44 visitors (0 registered, 44 guests [including 9 identified bots]).
Forum time: 05:34 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5